ELEVAR Trademark

Trademark Overview

On Tuesday, August 13, 2019, a trademark application was filed for ELEVAR with the United States Patent and Trademark Office. The USPTO has given the ELEVAR trademark a serial number of 88985333. The federal status of this trademark filing is SU - REGISTRATION REVIEW COMPLETE as of Thursday, February 15, 2024. This trademark is owned by Elevar Therapeutics, Inc.. The ELEVAR trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Research and development of experimental and novel cancer therapeutics prescribed by medical professionals and distributed to medical professionals and not directed to retail pharmacies and not directed to patients
elevar

General Information

Serial Number88985333
Word MarkELEVAR
Filing DateTuesday, August 13, 2019
Status819 - SU - REGISTRATION REVIEW COMPLETE
Status DateThursday, February 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 13, 2021

Trademark Statements

Translation of Words in MarkThe English translation of "ELEVAR" in the mark is "to raise".
Goods and ServicesResearch and development of experimental and novel cancer therapeutics prescribed by medical professionals and distributed to medical professionals and not directed to retail pharmacies and not directed to patients

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 28, 2019
Primary Code044
First Use Anywhere DateWednesday, October 16, 2019
First Use In Commerce DateWednesday, October 16, 2019

Trademark Owner History

Party NameElevar Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121
Party NameElevar Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121

Trademark Events

Event DateEvent Description
Friday, November 15, 2019NON-FINAL ACTION WRITTEN
Friday, August 16, 2019NEW APPLICATION ENTERED
Wednesday, August 28, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 12, 2019ASSIGNED TO EXAMINER
Friday, November 15, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 15, 2019NON-FINAL ACTION E-MAILED
Friday, May 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 21, 2020ASSIGNED TO LIE
Thursday, May 21, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 21, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 16, 2020FINAL REFUSAL WRITTEN
Tuesday, June 16, 2020NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, June 16, 2020FINAL REFUSAL E-MAILED
Thursday, August 20, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 20, 2020NON-FINAL ACTION WRITTEN
Thursday, August 20, 2020NON-FINAL ACTION E-MAILED
Tuesday, February 9, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 9, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 10, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 10, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 24, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 13, 2021PUBLISHED FOR OPPOSITION
Tuesday, April 13, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, December 8, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021SOU EXTENSION 1 FILED
Wednesday, December 8, 2021SOU EXTENSION 1 GRANTED
Friday, December 10, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 8, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, June 8, 2022SOU EXTENSION 2 FILED
Wednesday, June 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, June 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, June 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 15, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 8, 2022SOU EXTENSION 3 FILED
Wednesday, June 15, 2022SOU EXTENSION 2 GRANTED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 8, 2022SOU EXTENSION 3 GRANTED
Saturday, December 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 7, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, June 7, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, June 7, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 8, 2023SOU EXTENSION 4 FILED
Thursday, June 8, 2023SOU EXTENSION 4 GRANTED
Saturday, June 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 8, 2023DIVISIONAL REQUEST RECEIVED
Friday, December 8, 2023USE AMENDMENT FILED
Friday, December 8, 2023TEAS STATEMENT OF USE RECEIVED
Friday, December 8, 2023TEAS REQUEST TO DIVIDE RECEIVED
Monday, December 11, 2023DIVISIONAL PROCESSING COMPLETE
Monday, December 11, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 15, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, February 16, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Friday, February 16, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

elevar medical professionals directed distributed retail patients pharmacies prescribed experimental development